(Q42940084)

English

Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study

scientific article published on 12 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

author name string

Mitsuru Ohishi

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Yasushi Takeya

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Yuji Tatara

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Koichi Yamamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Miyuki Onishi

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Yoshihiro Maekawa

6

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Kei Kamide

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

publication date

12 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Hypertension Research

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1150-1154

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

https://scigraph.springernature.com/pub.10.1038/hr.2010.145

0 references

The metabolic syndrome and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Effects of vasopeptidase inhibition on renal function and tubuloglomerular feedback in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Renal protective effect in hypertensive patients: the high doses of angiotensin II receptor blocker (HARB) study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

21 January 2018

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.145

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2010.145

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42940084&oldid=1974097395"